|
Volumn 357, Issue 9264, 2001, Pages 1222-1223
|
NSAIDS and selective COX-2 inhibitors: Competition between gastroprotection and cardioprotection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
DICLOFENAC;
IBUPROFEN;
MISOPROSTOL;
NAPROXEN;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
ROFECOXIB;
DRUG EFFECT;
DRUG MECHANISM;
HEART INFARCTION;
HEART PROTECTION;
HUMAN;
ISCHEMIC HEART DISEASE;
MORBIDITY;
MORTALITY;
NOTE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RISK FACTOR;
STOMACH DISEASE;
THROMBOCYTE AGGREGATION INHIBITION;
|
EID: 0035925909
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(00)04451-2 Document Type: Note |
Times cited : (74)
|
References (13)
|